Question 1

What does Sino Biopharmaceutical do?

Accepted Answer

Sino Biopharmaceutical is a pharmaceutical company that engages in research, development and pharmaceutical products for treating diseases.

Question 2

In what sectors does Sino Biopharmaceutical operate?

Accepted Answer

Sino Biopharmaceutical operates in Biotechnology, Health Care, Health Diagnostics, Hospital, Medical.

Question 3

How many companies has Sino Biopharmaceutical acquired?

Accepted Answer

Sino Biopharmaceutical has made 4 acquisitions between 2021-2026, with a total disclosed deal value of $6.2B.

Question 4

What companies are owned by Sino Biopharmaceutical?

Accepted Answer

Companies acquired by Sino Biopharmaceutical include Hegea Bio, Lixin Pharmaceutical, LaNova Medicines, Softhale.

Question 5

What are Sino Biopharmaceutical's major acquisitions?

Accepted Answer

Sino Biopharmaceutical's largest acquisitions include Lixin Pharmaceutical ($5.0B, 2025), LaNova Medicines ($950.9M, 2025), Hegea Bio ($172.0M, 2026), Softhale ($110.0M, 2021).

Question 6

What is Sino Biopharmaceutical's largest acquisition?

Accepted Answer

Sino Biopharmaceutical's largest disclosed acquisition is Lixin Pharmaceutical for $5.0B (2025).

Question 7

What was Sino Biopharmaceutical's first acquisition?

Accepted Answer

Sino Biopharmaceutical's first recorded acquisition was Softhale in 2021 for $110.0M.

Question 8

What was Sino Biopharmaceutical's most recent acquisition?

Accepted Answer

Sino Biopharmaceutical's most recent acquisition is Hegea Bio, announced January 2026 for $172.0M.

Question 9

What is the average deal size for Sino Biopharmaceutical acquisitions?

Accepted Answer

The average disclosed deal size for Sino Biopharmaceutical acquisitions is $1.6B.

Question 10

What is the median deal size for Sino Biopharmaceutical acquisitions?

Accepted Answer

The median disclosed deal size for Sino Biopharmaceutical acquisitions is $561.5M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Sino Biopharmaceutical spent on acquisitions?

Accepted Answer

Sino Biopharmaceutical has spent at least $6.2B across its disclosed acquisitions (of 4 total deals; some prices are undisclosed).

Question 12

Which sector has Sino Biopharmaceutical spent the most on?

Accepted Answer

Sino Biopharmaceutical has committed the most disclosed capital to Health Care companies — about $6.1B across its deals in that sector.

Question 13

What sectors does Sino Biopharmaceutical usually acquire in?

Accepted Answer

Sino Biopharmaceutical most frequently acquires companies in Medical, Health Care, Biotechnology.

Question 14

In which sector has Sino Biopharmaceutical made the most acquisitions?

Accepted Answer

Sino Biopharmaceutical has made the most acquisitions in the Medical sector.

Question 15

In which year did Sino Biopharmaceutical make the most acquisitions?

Accepted Answer

Sino Biopharmaceutical made the most acquisitions in 2025, with 2 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Sino Biopharmaceutical

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Sino Biopharmaceutical

Acquisitions by Sino Biopharmaceutical

Explore 200,000+ acquisitions — free

Recent News related to Sino Biopharmaceutical

FAQs about Sino Biopharmaceutical

People who checked this page also checked these